The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica

New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica

April 6, 2012 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Another change from the previous ACR recommendations for OA management is that the 2012 document does not recommend a sequence of subsequent interventions if initial therapies for OA do not result in an adequate response. This change is due to a lack of high-quality studies that reliably examined the benefit and safety of treatment modalities that could support recommendations of a specific sequence of therapy.

You Might Also Like
  • ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome
  • Polymyalgia Rheumatica
  • How to Manage Polymyalgia Rheumatica
Explore This Issue
April 2012
Also By This Author
  • Bariatric Surgery May Help Obese Patients with Gout, Diabetes

According to Dr. Hochberg, nonpharmacologic and pharmacologic therapies were given “equal weighting” in panel deliberations and literature reviews for the 2012 recommendations. “The nondrug treatments were given a lot of attention because they are the cornerstone of the management approach to people with OA. We find [they are] often neglected in primary care because of the short amounts of time that providers have to interact with their patients,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Unlike the previous ACR recommendations, the 2012 document includes recommendations for management of symptomatic hand OA.

Key Recommendations

Dr. Hochberg highlighted some of the key points among the recommendations:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Topical rather than oral nonsteroidal antiinflammatory drugs (NSAIDs) should be used whenever possible for people over age 75 years, a recommendation in accord with the American Geriatric Society.
  • For hand OA, provision of assistive devices, use of thermal modalities and trapeziometacarpal joint splints, and use of oral and topical NSAIDs, tramadol, and topical capsaicin are conditionally recommended.
  • Also for management of hand OA, it is conditionally recommended that intraarticular therapies and opioids not be used.
  • Acetaminophen, recommended previously as initial therapy for knee and hip OA, is now only conditionally recommended among other pharmacologic agents, such as oral and topical NSAIDs, which can be used as initial therapy in patients with hip and knee OA.
  • Aerobic, aquatic, resistance exercises, and weight loss are strongly recommended for knee and hip OA.
  • For both knee and hip OA, nutraceuticals such as chondroitin sulfate, glucosamine, and topical capsaicin are conditionally recommended not to be used.
  • Tai chi is conditionally recommended for knee OA, as is acupuncture in certain situations; no recommendation is given for tai chi for hip OA.
  • Management is addressed for those patients who would normally be referred to orthopedic surgeons but who choose not to have a joint replacement or are not medically suitable for surgery.

Some of the recommendations may come as a surprise to rheumatologists, Dr. Hochberg predicts, including the recommendation related to topical therapy for knee OA for all age groups, and particularly for those over age 75. “I think most rheumatologists are not aware of it and have a feeling that it does not work as well as oral therapy,” he says, “However, the data from clinical trials indicate that it does work.”

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Guidelines, Osteoarthritis, Systemic Inflammatory Syndromes Tagged With: AC&R, American College of Rheumatology, Classification Criteria, Guidelines, Osteoarthritis, Polymyalgia Rheumatica, rheumatologist, Sjögren's syndromeIssue: April 2012

You Might Also Like:
  • ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome
  • Polymyalgia Rheumatica
  • How to Manage Polymyalgia Rheumatica
  • Corticosteroid Use in Acute Polymyalgia Rheumatica Should be Reassessed

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)